← Open Payments lookup

MARY MCMANMON: Open Payments

NPI 1255363172 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$367 in 20 payments from 8 companies in 2025. Trend: 2023 $457 · 2024 $330 · 2025 $367

Food & beverage: $367
CompanyPaymentsAmount
ABBVIE INC.11$200
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
GlaxoSmithKline, LLC.2$29
Aimmune Therapeutics, Inc.1$27
Gilead Sciences, Inc.1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Merck Sharp & Dohme LLC1$16
Amgen Inc.1$15

Products named: VRAYLAR, JARDIANCE, TRELEGY ELLIPTA, ZENPEP, CAPLYTA, VAXELIS, REPATHA, MAVYRET.

Industry payments across IN — which companies pay providers there.